Mentioned On
Episode Mentions
Freakonomics Radio · Apr 17, 2026
671. Why Has There Been So Little Progress on Alzheimer’s Disease?
“Cassava Sciences rebranded name after paying $40M SEC settlement; now focusing on rare epilepsy treatment development”
Amyloid Cascade Hypothesis in Alzheimer's ResearchScientific Image Manipulation and Forensic DetectionResearch Integrity and Misconduct in Neuroscience
View Analysis